1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. BELLUS Health Inc
  6. News
  7. All News
       CA07987C1059

BELLUS HEALTH INC

Delayed Toronto Stock Exchange  -  08/30 04:00:00 pm EDT
9.340 CAD   +6.02%
05/11BELLUS : Q1 Earnings Snapshot
AQ
05/11Bellus Health Reports Q1 Net Loss of US$14.4 Million, Provides Update
MT
05/11BELLUS Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryChartsNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about BELLUS HEALTH INC
05/11BELLUS : Q1 Earnings Snapshot
AQ
05/11Bellus Health Reports Q1 Net Loss of US$14.4 Million, Provides Update
MT
05/11BELLUS Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/11Earnings Flash (BLU.TO) BELLUS HEALTH Says Ended Q1 2022 with US$234.0 million in cash,..
MT
05/11Earnings Flash (BLU.TO) BELLUS HEALTH Posts Q1 Basic and Diluted Loss US$0.13
MT
05/11BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
BU
05/11TRANSCRIPT : BELLUS Health Inc. - Shareholder/Analyst Call
CI
05/02BELLUS HEALTH : to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of B..
PU
05/02BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of ..
BU
05/02BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of ..
CI
04/25BELLUS HEALTH : to Participate in Multiple Upcoming Investor Conferences - Form 6-K
PU
04/25BELLUS Health to Participate in Multiple Upcoming Investor Conferences
BU
04/07BELLUS HEALTH : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K
PU
04/06BELLUS HEALTH : Form of Proxy – Annual General Meeting
PU
04/05BELLUS HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K
PU
04/01RBC Capital on Bellus Health's BLU-5937'S Path Forward
MT
04/01BELLUS HEALTH : Corporate Presentation – April 2022
PU
03/18RBC Capital Keeps Outperform/Speculative, US$14 TP on Bellus, Says Physician Surveys Su..
MT
03/08TRANSCRIPT : BELLUS Health Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-..
CI
03/04BELLUS HEALTH : Notice of the Meeting and Record Date - Form 6-K
PU
03/01BELLUS HEALTH : Corporate Presentation – March 2022
PU
03/01RBC Capital Markets Maintains BELLUS Health's Rating, Price Target
MT
03/01BELLUS HEALTH : to Participate in the Cowen & Co. 42nd Annual Health Care Conference - For..
PU
03/01BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
BU
02/24RBC Capital Reiterates Outperform/Speculative Risk, US$14 TP on Bellus Health
MT
02/24HC Wainwright Adjusts BELLUS Health's Price Target to $16 From $14, Reiterates Buy Rati..
MT
02/23BELLUS : Q4 Earnings Snapshot
AQ
02/23BELLUS HEALTH : Annual Report by Canadian Issuer (Form 40-F)
PU
02/23BELLUS Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
02/23Bellus Health Reports FY 2021 Net Loss of US$0.90 Per Share
MT
02/23BELLUS HEALTH : Reports Year 2021 Financial Results and Business Highlights - Form 6-K
PU
02/23BELLUS HEALTH BRIEF : Ended year with US$248.8 million in cash, cash equivalents and short..
MT
02/23BELLUS HEALTH BRIEF : Comes As Announced "Positive" topline results from Phase 2b SOOTHE c..
MT
02/23BELLUS HEALTH BRIEF : Says Plans to request an End-of-Phase 2 meeting with Food and Drug A..
MT
02/23BELLUS Health Reports Year 2021 Financial Results and Business Highlights
BU
02/23NORTH AMERICAN MORNING BRIEFING : Stocks to -2-
DJ
02/11BELLUS HEALTH : Corporate Presentation – February 2022
PU
02/04RBC Capital Keeps Outperform/Speculative Risk, US$14 TP on Bellus Health
MT
01/24U.S. FDA declines to approve Merck's cough drug
RE
01/11RBC Capital Keeps Outperform/Speculative Risk Rating, US$14 TP on Bellus Health
MT
2021BELLUS HEALTH : Corporate Presentation – December 2021
PU
2021BELLUS HEALTH INC.(NASDAQGS : BLU) added to NASDAQ Biotechnology Index
CI
2021BELLUS HEALTH : Closes US$200 Million Public Offering of Common Shares in Canada and the U..
PU
2021BELLUS Health Closes US$200 Million Offering
MT
2021BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the ..
BU
2021RBC Capital Markets Raises BELLUS Health's Price Target, Reiterates Rating
MT
2021RBC Lifts Price Target on BELLUS Health to $14 From $11, Citing 'Strengthening Clinical..
MT
2021BELLUS HEALTH : Announces Pricing of US$200 Million Public Offering in Canada and the Unit..
PU
2021BELLUS Health Prices US$200 Million Public Offering in Canada and the United States
MT
2021BELLUS HEALTH BRIEF : Up 0.2% In US Pre-Market After Overnight Pricing US$200 Million Publ..
MT
2021BELLUS Health Prices Public Offering in Canada, US at $8/Share, Expects $200 Million Gr..
MT
2021BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the Uni..
BU
2021CORRECTION : Top Midday Gainers
MT
2021BELLUS Health Launches Public Offering of Common Shares in Canada and the U.S.; Shares ..
MT
2021BELLUS Health Launches Common Stock Offering in Canada, US
MT
2021BELLUS HEALTH : Announces the Launch of a Public Offering of Common Shares in Canada and t..
PU
2021BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and ..
BU
2021Health Care Stocks Finishing Near Intra-Day Highs
MT
2021SECTOR UPDATE : Health Care
MT
2021Top Midday Decliners
MT
2021Evercore ISI Adjusts Price Target on BELLUS Health to $20 From $12, Maintains Outperfor..
MT
2021BTIG Research Adjusts BELLUS Health PT to $18 From $13, Maintains Buy Rating
MT
2021BELLUS Health up 62% on TSX to 18-Month High on "Positive" Topline Results From Phase 2..
MT
2021IIROC Trade Resumption - BLU
AQ
2021IIROC Trading Halt - BLU
AQ
2021Wall Street Set for Positive Open, S&P 500 Futures Poised to Add to Friday's Record Clo..
MT
2021BELLUS Health up 43% to Fresh Year High in US Pre-Market on "Positive" Topline Results ..
MT
2021BELLUS Health up 36% to 52-Week High in US Pre-Market on "Positive" Topline Results Fro..
MT
2021Top Premarket Gainers
MT
2021TRANSCRIPT : BELLUS Health Inc. - Special Call
CI
2021BELLUS Health Details "Positive" Topline Results From Phase 2b SOOTHE Trial For Treatm..
MT
2021BELLUS HEALTH BRIEF : Details "Positive" Topline Results from its Phase 2b SOOTHE Trial of..
MT
2021BELLUS HEALTH : Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5..
PU
2021BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-..
BU
2021Bellus Health Announces Positive Topline Results from Its Phase 2B Soothe Trial of Blu-..
CI
1  2  3  4  5Next
Upcoming event on BELLUS HEALTH INC